Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: Meisterama who wrote (2779)	6/30/1999 5:29:00 PM
From: Meisterama	Respond to of 2887

I've been doing a LOT of searching lately, and I have found NO products either FDA-approved or even patented, which compete with the Omnifilter. If this is true, then ITI could be the first to market with such a device. And the guidewire design of the Omnifilter may make it extremely versatile with a range of catheter products. So if the Omnifilter product is approved, ITI (and ABMI) may be sitting on an immensely valuable product. And ITI's payment of a million bucks to ABMI seems to support that. I see so much good news in the ITI deal, it's incredible. Come on Steve Rash, let's get the word out and get new investors excited about this! Yes, the product is still not approved, but the potential is great enough that speculative investors should be jumping in. And if 510K is obtained, things could start happening as early as a few months from now. So it seems like there's no reason the market shouldn't be recognizing this now.

To: Meisterama who wrote (2779)	6/30/1999 8:12:00 PM
From: samcat9	Read Replies (3) \| Respond to of 2887

Meisterama, I have no special knowledge about ABMI, Rash, ... or ABMI's products. However, I strongly believe that ABMI is currently in the best financial position it has been in for years. Unfortunately, all of the hype done by certain persons in the past unrealistically inflated the expectations of investors, which has resulted in a lack of confidence in the company at the current time. I did not fully realize what a bad financial position ABMI was in when I bought my stock, but I believed that its products and its patents were valuable if the proper approvals could be obtained and they could be taken to market in an effective way. Unfortunately, ABMI did not have the funds to obtain the approval and market the products. I remain optimistic about the current deals with the venture capitalists. If they did not believe they could not make money, they would not have acted. The $1 million payment is evidence of their beliefs in ABMI. I share many of your views about ABMI. I will post more of my thoughts at at a later date. Thank you for sharing your thoughts. samcat